{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T21:42:32Z","timestamp":1766180552172},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,15]]},"DOI":"10.1097\/tp.0b013e318294caf1","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T17:50:09Z","timestamp":1369158609000},"page":"108-115","source":"Crossref","is-referenced-by-count":6,"title":["Costs of Second Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1097","volume":"96","author":[{"given":"Nandita","family":"Khera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Storer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda M.","family":"Sandmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael K.","family":"Chapko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20210129","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.bmt.1703389","article-title":"Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation.","volume":"29","author":"Wolff","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"R2-19-20210129","first-page":"1176","article-title":"Is there a future for auto-allo HSCT in multiple myeloma Lancet O","volume":"12","author":"Dispenzieri","year":"2011","journal-title":"ncol"},{"key":"R4-19-20210129","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MOH.0b013e3283257a87","article-title":"Second hematopoietic stem cell transplantation in myeloid malignancies.","volume":"16","author":"Arfons","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"R5-19-20210129","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1200\/JCO.2006.06.9914","article-title":"Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.","volume":"24","author":"Baron","year":"2006","journal-title":"J Clin Oncol"},{"key":"R6-19-20210129","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1200\/JCO.2001.19.16.3675","article-title":"Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation.","volume":"19","author":"Bosi","year":"2001","journal-title":"J Clin Oncol"},{"key":"R7-19-20210129","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.bmt.1704645","article-title":"Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.","volume":"34","author":"Eapen","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R8-19-20210129","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2141.2000.02306.x","article-title":"Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation.","volume":"111","author":"Guardiola","year":"2000","journal-title":"Br J Haematol"},{"key":"R9-19-20210129","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.bbmt.2009.06.011","article-title":"Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.","volume":"15","author":"Gyurkocza","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"R10-19-20210129","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bbmt.2003.08.003","article-title":"Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia.","volume":"9","author":"Meshinchi","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"R11-19-20210129","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2141.2000.01851.x","article-title":"Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de moelle (SFGM).","volume":"108","author":"Michallet","year":"2000","journal-title":"Br J Haematol"},{"key":"R12-19-20210129","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3324\/haematol.12798","article-title":"Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantation.","volume":"93","author":"Platzbecker","year":"2008","journal-title":"Haematologica"},{"key":"R13-19-20210129","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1083-8791(00)70009-7","article-title":"Second allogeneic transplantation after failure of first autologous transplantation.","volume":"6","author":"Radich","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"R14-19-20210129","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1182\/blood-2004-01-0231","article-title":"Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.","volume":"104","author":"Freytes","year":"2004","journal-title":"Blood"},{"key":"R15-19-20210129","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.2000.18.23.3918","article-title":"Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkins disease and non-Hodgkins lymphoma.","volume":"18","author":"Carella","year":"2000","journal-title":"J Clin Oncol"},{"key":"R16-19-20210129","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S1470-2045(11)70243-1","article-title":"Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial.","volume":"12","author":"Krishnan","year":"2011","journal-title":"Lancet Oncol"},{"key":"R17-19-20210129","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood-2002-01-0131","article-title":"Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma.","volume":"100","author":"Kroger","year":"2002","journal-title":"Blood"},{"key":"R18-19-20210129","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2002-09-2955","article-title":"Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.","volume":"102","author":"Maloney","year":"2003","journal-title":"Blood"},{"key":"R19-19-20210129","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.bmt.1701600","article-title":"Retrospective survival analysis and cost-effectiveness evaluation of second allogeneic bone marrow transplantation in patients with acute leukemia. Gruppo Italiano Trapianto di Midollo Osseo.","volume":"23","author":"Messori","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"R20-19-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1200\/JCO.2000.18.1.64","article-title":"Predicting costs of stem-cell transplantation.","volume":"18","author":"Lee","year":"2000","journal-title":"J Clin Oncol"},{"key":"R21-19-20210129","first-page":"805","article-title":"Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made J Clin O","volume":"29","author":"Horan","year":"2011","journal-title":"ncol"},{"key":"R22-19-20210129","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1182\/blood-2012-05-426783","article-title":"Economics of hematopoietic cell transplantation.","volume":"120","author":"Khera","year":"2012","journal-title":"Blood"},{"key":"R23-19-20210129","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/bmt.2011.162","article-title":"Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation.","volume":"47","author":"Svahn","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"R24-19-20210129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00000658-200212000-00003","article-title":"Decision for retransplantation of the liver: an experience- and cost-based analysis.","volume":"236","author":"Azoulay","year":"2002","journal-title":"Ann Surg"},{"key":"R25-19-20210129","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/bmt.2009.300","article-title":"Management of relapse after allo-SCT for AML and the role of second transplantation.","volume":"44","author":"Savani","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"R26-19-20210129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1377\/hlthaff.20.5.101","article-title":"The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer.","volume":"20","author":"Mello","year":"2001","journal-title":"Health Affairs (Project Hope)"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e318294caf1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T23:08:46Z","timestamp":1715382526000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201307150-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,15]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318294caf1","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7,15]]}}}